Compare CMG & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMG | EW |
|---|---|---|
| Founded | 1993 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1B | 45.5B |
| IPO Year | 2006 | 2000 |
| Metric | CMG | EW |
|---|---|---|
| Price | $33.91 | $86.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 21 |
| Target Price | $48.71 | ★ $94.68 |
| AVG Volume (30 Days) | ★ 22.8M | 3.5M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.56 | N/A |
| EPS | 1.13 | ★ 2.33 |
| Revenue | ★ $11,787,400,000.00 | $5,883,800,000.00 |
| Revenue This Year | $6.29 | $14.26 |
| Revenue Next Year | $9.78 | $9.77 |
| P/E Ratio | ★ $30.06 | $37.70 |
| Revenue Growth | 7.31 | ★ 10.60 |
| 52 Week Low | $29.75 | $65.94 |
| 52 Week High | $66.74 | $87.89 |
| Indicator | CMG | EW |
|---|---|---|
| Relative Strength Index (RSI) | 50.23 | 59.20 |
| Support Level | $33.43 | $83.60 |
| Resistance Level | $34.59 | $87.40 |
| Average True Range (ATR) | 1.02 | 1.76 |
| MACD | 0.61 | -0.28 |
| Stochastic Oscillator | 74.92 | 63.57 |
Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $11.3 billion in 2024. The Mexican concept is almost exclusively company-owned, with just three license stores operated through a master franchise relationship with Alshaya Group in the Middle East. It had a footprint of 3,726 stores at the end of 2024, heavily indexed to the United States, although it maintains a small presence in Canada, the UK, France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.